Minireviews
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jan 28, 2022; 28(4): 449-463
Published online Jan 28, 2022. doi: 10.3748/wjg.v28.i4.449
Table 1 DNA methylation features in celiac disease
Predisposition to CeD
What
Result
Highlight in CeD
Allele-specific methylation (ASM)[24]ASM in rs2762051 in DLEU1 geneLinked to CeD phenotype
Rs906868 in LBH gene promoter[23]Risk variant shared with RADisease-specific methylationDifferent methylation in rs906868 can predispose to CeD or RA
→ influence on Wnt signalling
Methylation in HLA region in CeD[30]Specific patterns in epithelial and immune cellsGenotype-independent methylation (except for HLA-DPB2)Methylation patterns in HLA region
→ CeD predisposition
Methylation profiling in HLA-DQB1 and SLC17A3[32]Bead-chip on saliva samplesDifferent methylation profiles, not confirmed in bigger cohortPotential methylation-based screening
Major validation needed
Opioid like-effect of gliadin[27]Modulation of glutathione and DNA methylationPredisposition to inflammation and oxidation
CeD pathogenesis
Methylation in NFkB-related genes[26]NFkB pathway↑↑Disruption of regulatory equilibriumCo-methylation patterns typical of active CeD in NFkB pathway genes
Cell-specific methylation[30]Epithelium → 43 DMPCell-specific methylation signature & gene expression in CeD vs controls
Immune cells → 310 DMP
Different methylation of SB2H3, IL-21, cREL and TNFAIP3[31]Epithelium and lamina propria - specificityCorrelation with pro-inflammatory(↑) and cell adhesion(↓) pathwaysMethylation of SB2H3 → epithelium
Methylation of IL21 → lamina propria
Typical of CeD samples.
Tumor development
↑CpGs methylation[20]Microsatellite instability ↓MLH1 expressionTypical in CeD-related small bowel adenocarcinoma
MLH1 deregulation[21]APC gene hyper-methylationChromosomal aberrations/microsatellite instabilityDefects in mismatch repair
Typical in CeD-related small bowel adenocarcinomas
Microsatellite instability[22]Typical CpGs methylator phenotypeMethylation profiling → phenotypical classification Mesenchymal and immune phenotypes are common in CeD-related small bowel carcinoma